Acknowledgements
This work was performed under the Care4Rare Canada Consortium funded by
Genome Canada and the Ontario Genomics Institute (OGI-147), the Canadian
Institutes of Health Research, Ontario Research Fund, Genome Alberta,
Genome British Columbia, Genome Quebec, and Children’s Hospital of
Eastern Ontario Foundation. T.H. was supported by a Frederick Banting
and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR.
K.M.B. was supported by a CIHR Foundation Grant (FDN-154279) and a Tier
1 Canada Research Chair in Rare Disease Precision Health.